Kava

DB01322ApprovedInvestigationalNutraceuticalWithdrawnSmall molecule

Kava: Overview.

Mechanism: Pharmacologically active on Amine oxidase [flavin-containing] B and Nuclear factor NF-kappa-B complex
Curator reviewed
Formula / weight: C₁₄H₁₆O₃ · 232.275 g/mol (avg)

Resolves to

Compound

Clinical / RWD

Structure

InChIKeyOMNGEVNATYFZGG-BQYQJAHWSA-NSMILESCOC1=CC(=O)OC(C1)\C=C\C1=CCCC=C1

Targets

Transporters

What you can answer from here — as of August 31, 2026

4Protein targetsEach mapped to UniProt, with action and pharmacological action

Listed above

1TransporterSubstrate / inhibitor direction, not just membership

Listed above

10Clinical trialsPhase, status and sponsor resolved per trial

20+ReferencesStructured and connected to the statements they support

Which drugs share a target with Kava, and which of those have an active Phase 3 trial?

Create a free account or log in to explore the full data card.